Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute.
D000818:Animals; D001216:Asparagine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000633:toxicity; D002415:Cats; D004355:Drug Stability; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D006128:Growth / Q000187:drug effects*; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D051379:Mice; D010455:Peptides / Q000494:pharmacology / Q000633:toxicity*; D010952:Plasma Substitutes / Q000494:pharmacology / Q000633:toxicity*; D011247:Pregnancy; D011817:Rabbits; D051381:Rats
D010455:Peptides; D010952:Plasma Substitutes; D001216:Asparagine